Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2026-04-02 16:39:16 ET · period of report 2026-04-01 · accession 0001725663-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-02 16:39 | 2026-04-01 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale | $12.95 | -2,500 | 119.0K | -2% | -$32.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | S | D | 2,500 | $12.95 | 119,010 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025. |